Stents Clinical Trial
Official title:
A Solution for Medical and Legal Problems Arising From Forgotten Ureteral Stents: Reminder Short Message Service (SMS)
Ureteral stents has become an indispensable instrument for urology practice as a result of widespread use of endourological interventions. Removal of stents could be sometimes neglected by patients or physicians. This omission may lead to legal and medical problems for urologists, health institutions and also for patients. In this study, the investigators offer a computer program providing two sided recall to prevent this nasty complication with sending automatic message by short message service (SMS) to both the patient and the urologist.
In this study, first an institutional subscription agreement was signed between our
university and a mobile phone cell company which is supporting SMS sending program. In the
second step, by making software plug-in to our hospital's patient follow up program, two
programs were integrated. According to this integration, after stent insertion, in case of
entering the numerical code corresponding of ''ureteral stent application'' procedure during
the stage of epicrisis preparation, the patient follow up system warns the official
recording the epicrisis to enter the stent removal time. Patient follow up system transfers
this information to SMS sending program. After several weeks of the procedure, if the stent
needs to be removed, the software automatically sends a warning message to the patient and
the physician. If the patients attends to urology department and undergoes stent removal,
the official enters the code of "endoscopic stent removal" to the patient follow-up program.
Then the program stops to send warning message.
By the software plug-in to patient follow up program, SMS sending was made mandatory not to
forget or skip none of the patients during the epicrisis writing procedure.
;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01900691 -
Removal of the Evolution® Esophageal Stent - Fully Covered
|
N/A | |
| Recruiting |
NCT05872074 -
Immediate and Short Term Outcomes for Using Drug Coated Balloons in Treating Coronary Bifurcation Lesions
|
N/A | |
| Completed |
NCT04115696 -
Biodegradable Stent Implantation in Biliary Benign Strictures.
|
||
| Completed |
NCT01124942 -
MGuard Stent in ST-elevation Myocardial Infarction
|
N/A | |
| Completed |
NCT02811796 -
Angio-based Fractional Flow Reserve to Predict Adverse Events After Stent Implantation
|
||
| Recruiting |
NCT01997242 -
The Surgery After Stenting (SAS) Registry
|
N/A | |
| Completed |
NCT01056744 -
Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents
|
Phase 4 | |
| Completed |
NCT00691314 -
Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis
|
N/A | |
| Completed |
NCT00180479 -
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)
|
Phase 3 | |
| Completed |
NCT03521700 -
Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT01160900 -
FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization.
|
Phase 3 | |
| Completed |
NCT00937573 -
Xience V at Wake Forest University Baptist Medical Center (WFUBMC)
|
N/A | |
| Recruiting |
NCT00637104 -
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
|
Phase 2/Phase 3 | |
| Completed |
NCT03989557 -
Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms
|
Phase 4 | |
| Withdrawn |
NCT03375411 -
First-in-Man Study: Safety and Efficacy of INC-1 Bare Metal Stent in the Novo Coronary Lesions.
|
N/A | |
| Completed |
NCT01962168 -
Evolution® Biliary Stent System Clinical Study
|
N/A | |
| Completed |
NCT00769938 -
WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)
|
Phase 4 | |
| Completed |
NCT05556668 -
Percutaneous Biodegradable Biliary Stents for the Treatment of Benign Biliary Strictures.
|
||
| Terminated |
NCT03119012 -
P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
|
Phase 4 |